1. Home
  2. IMAB vs SATL Comparison

IMAB vs SATL Comparison

Compare IMAB & SATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • SATL
  • Stock Information
  • Founded
  • IMAB 2014
  • SATL 2010
  • Country
  • IMAB United States
  • SATL Uruguay
  • Employees
  • IMAB N/A
  • SATL N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • SATL Radio And Television Broadcasting And Communications Equipment
  • Sector
  • IMAB Health Care
  • SATL Technology
  • Exchange
  • IMAB Nasdaq
  • SATL Nasdaq
  • Market Cap
  • IMAB 83.8M
  • SATL 95.7M
  • IPO Year
  • IMAB 2020
  • SATL N/A
  • Fundamental
  • Price
  • IMAB $1.06
  • SATL $1.03
  • Analyst Decision
  • IMAB Strong Buy
  • SATL
  • Analyst Count
  • IMAB 3
  • SATL 0
  • Target Price
  • IMAB $8.00
  • SATL N/A
  • AVG Volume (30 Days)
  • IMAB 410.6K
  • SATL 67.0K
  • Earning Date
  • IMAB 08-28-2024
  • SATL 11-26-2024
  • Dividend Yield
  • IMAB N/A
  • SATL N/A
  • EPS Growth
  • IMAB N/A
  • SATL N/A
  • EPS
  • IMAB N/A
  • SATL N/A
  • Revenue
  • IMAB $3,492,091.00
  • SATL $13,719,000.00
  • Revenue This Year
  • IMAB N/A
  • SATL N/A
  • Revenue Next Year
  • IMAB N/A
  • SATL N/A
  • P/E Ratio
  • IMAB N/A
  • SATL N/A
  • Revenue Growth
  • IMAB N/A
  • SATL 101.51
  • 52 Week Low
  • IMAB $0.99
  • SATL $0.71
  • 52 Week High
  • IMAB $2.54
  • SATL $2.52
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 40.43
  • SATL 54.00
  • Support Level
  • IMAB $1.02
  • SATL $0.93
  • Resistance Level
  • IMAB $1.12
  • SATL $1.09
  • Average True Range (ATR)
  • IMAB 0.08
  • SATL 0.05
  • MACD
  • IMAB -0.01
  • SATL 0.01
  • Stochastic Oscillator
  • IMAB 20.00
  • SATL 53.12

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About SATL Satellogic Inc.

Satellogic Inc is a provider of satellite imagery to governments and commercial customers globally. It geographically operates in North America, Europe, Asia and South America. It derives maximum revenue from Asia Pacific.

Share on Social Networks: